Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MOLECULIN-BIOTECH-INC-27862535/news/Moleculin-Announces-U-S-Patent-Issue-Notification-for-Annamycin-Targeting-Unmet-Need-in-AML-46300061/?utm_source=whatsapp&utm_medium=social&utm_campaign=share